Merck
CN
Search Within
文件类型

135-70-6

应用筛选条件
关键词:'135-70-6'
显示 1-30 共 252 条结果 关于 "135-70-6" 范围 技术文档
Product Information Sheet - VP002
Orbital Diameter (mm) Shaking Speed (rpm) 125 mL 30 25 135 250 mL 60 25 135 500 mL 120 25 135 1,000 mL 300 25 135 2,000 mL 600 25 135 3,000 mL 1,200 25 96
Microsoft Word - VP001 tech bulletin final
Orbital Diameter (mm) Shaking Speed (rpm) 125 mL 30 25 135 250 mL 60 25 135 500 mL 120 25 135 1,000 mL 300 25 135 2,000 mL 600 25 135 3,000 mL 1,200
Aldrich Polymer Products Application - Initiators
(aliphatic hydrocarbons) 24,750-2 Cumene hydroperoxide Benzene 115 4.0 x 10-7 135 (toluene) 145 6.6 x 10-6 28,908-6 Cyclohexanone peroxide Benzene 90 (benzene) 32,954-1 Dicumyl peroxide Benzene 115
Data Sheet - N1533
Storage/Stability Recombinant bovine eNOS should be stored at or below −70 °C. The solution will be stable for at least 6 months at that temperature. The enzyme loses approximately 10% of its activity
RABBIT ANTI-TRK B
lyophilized material at -20°C to -70°C for up to 6 months after date of receipt. After reconstitution maintain frozen at -20°C to -70°C in undiluted aliquots for up to 6 months. Avoid repeated freeze/thaw
Complement C9 (C3660)
1291-1296 (1980). 2. Kolb, W.P. et al., J. Exp. Med., 135(3), 549-566 (1972). 3. Hadding, U., and Müller-Eberhard, H.J., Immunology, 16(6), 719-735 (1969). 4. Kolb, W.P., and Müller-Eberhard
C1 Esterase Inhibitor from Human plasma
kDA. The product is supplied in phosphate buffered saline, pH 7.4, (15 mM sodium phosphate and 135 mM sodium chloride. Activity: C1 esterase inhibitor (C1EI) functional activity is determined
Spare parts for Mobius® FlexReady Solution with Smart Flexware® Assemblies For Chromatography and TFF
133 134 135 149 78 134 140 145 152 144 141 139 142 129 135 133 126 128 149 132 143 127
Data Sheet - N3893
7.4, (2 x 10 ml). 6. Add 1 ml/plate of (1x) boiling sample buffer and scrape cells. 7. Boil sample for 5 min. at 95 °C. 8. Aliquot samples of cells extracts and store at –70 °C. Preparation
Complement C8 (C3535)
709-715 (1977). 5. Podack, E.R. et al., J. Immunol., 121(2), 484-490 (1978). 6. Kolb, W.P. et al., J. Exp. Med., 135(3), 549-566 (1972). 7. Kolb, W.P., and Müller-Eberhard, H.J., J. Exp. Med
Quality Control Range Sheet- RMY-103 and RMY-203
533 - 1106 pg/mL Control 2 867 - 1801 pg/mL IL-6 Control 1 4.2 - 8.6 ng/mL SPARC Control 1 3.2 – 6.6 ng/mL Control
Cholesterol Oxidase from microorganisms (C5421)
endpoint method. Clin. Chim. Acta, 339, 135-45 (2004). 5. Allain, C.C., et al., Enzymatic determination of total serum cholesterol. Clin. Chem., 20, 470-75 (1974). 6. MacLachlan, J., et al., Cholesterol
Monitoring low dose API blend uniformity with Parteck® M
content obtained by primary method vs model predicted values. 0 1 2 3 6 7 84 9 10 11 130 90 100 110 120 80 70 D ru g co
Product Information Sheet - WTA1
incubate at 70 °C for 5 minutes. 4. Cool reaction immediately on ice and spin down any condensation by centrifugation. 5. Add 1 µL of WTA Library Synthesis Enzyme and mix by pipetting. 6. Incubate
Data Sheet - K2768 - Lot 061M0751
0.25 mM DTT, 0.1 mM EGTA, 0.1 mM EDTA, 0.1 mM PMSF, and 25% glycerol. Molecular mass: ∼135 kDa Purity: ≥70% (SDS-PAGE, see Figure 1) Specific Activity: 73–99 nmole/min/mg (see Figure 2) Precautions
Data Sheet - K2768 - Lot 080M0894
0.25 mM DTT, 0.1 mM EGTA, 0.1 mM EDTA, 0.1 mM PMSF, and 25% glycerol. Molecular mass: ∼135 kDa Purity: ≥70% (SDS-PAGE, see Figure 1) Specific Activity: 73–99 nmole/min/mg (see Figure 2) Precautions
Data Sheet - K2768 - Lot 019K0624
0.25 mM DTT, 0.1 mM EGTA, 0.1 mM EDTA, 0.1 mM PMSF, and 25% glycerol. Molecular mass: ∼135 kDa Purity: ≥70% (SDS-PAGE, see Figure 1) Specific Activity: 73–99 nmole/min/mg (see Figure 2) Precautions
Data Sheet - K2768 - Lot 079K0753
0.25 mM DTT, 0.1 mM EGTA, 0.1 mM EDTA, 0.1 mM PMSF, and 25% glycerol. Molecular mass: ∼135 kDa Purity: ≥70% (SDS-PAGE, see Figure 1) Specific Activity: 73–99 nmole/min/mg (see Figure 2) Precautions
Data Sheet - N2783
hazards and safe handling practices. Storage The product should be stored at –70 C. It will remain active for at least 6 months at that temperature. The enzyme loses 10% of its activity after a single
Data Sheet - N1783
. Storage/Stability Mouse iNOS should be stored at or below −70 °C. The solution will be stable for at least 6 months at that temperature. The enzyme loses approximately
Data Sheet - N3033
Storage/Stability Recombinant rat bNOS should be stored at or below −70 °C. The solution will be stable for at least 6 months at that temperature. The enzyme loses approximately 40% of its activity
Data Sheet - P6111
sequence. Anti-phospho-Phospholipase C γ-1 (pTyr783) recognizes the endogenous form of PLC γ protein (135 kDa) when phosphorylated on tyrosine 783 and does not cross- react with a site-directed mutant (Y783F
Data Sheet - SRP5240
glutathione, 0.1 mM EDTA, 0.25 mM DTT, 0.1 mM PMSF, and 25% glycerol. Molecular mass: ∼135 kDa Purity: 70–95% (SDS-PAGE, see Figure 1) Specific Activity: 5.3–7.1 nmole/min/mg (see Figure 2)
Data Sheet - A0608 - Lot 041M1004
mM NaCl, 150 mM imidazole, 0.1 mM PMSF, 0.2 mM DTT, and 25% glycerol. Molecular mass: ∼135 kDa Purity: ≥70% (SDS-PAGE, see Figure 1) Specific Activity: 717–971 nmole/min/mg (see Figure 2) Precautions
Data Sheet - SRP5090
TEC protein tyrosine kinase inhibits CD25 expression in human T-lymphocytes. Immunol. Lett., 127, 135-142 (2010). PRECISIO is a registered trademark of Sigma-Aldrich Co. LLC. TD,MAM 11/11-1 
Intestine dECM Gel Hydrogel Kit
thoroughly by vortexing the mixture. 3. Add 135 µL cell culture media into the ECM/Component mixture from step 2 to yield a final hydrogel concentration of 6 mg/mL. Mix thoroughly by vortexing. Note: While
Skin dECM Gel Hydrogel Kit
thoroughly by vortexing the mixture. 3. Add 135 µL cell culture media into the ECM/Component mixture from step 2 to yield a final hydrogel concentration of 6 mg/mL. Mix thoroughly by vortexing. Note: While
Data Sheet - N2643
7.4 (2 x 10 ml). 6. Add 1 ml/plate of (1x) boiling sample buffer and scrape cells. 7. Boil sample for 5 min. at 95 °C. 8. Aliquot samples of cells extracts and store at –70
Liver dECM Gel Hydrogel Kit
thoroughly by vortexing the mixture. 3. Add 135 µL cell culture media into the ECM/Component mixture from step 2 to yield a final hydrogel concentration of 6 mg/mL. Mix thoroughly by vortexing. Note: While
Heart dECM Gel Hydrogel Kit
thoroughly by vortexing the mixture. 3. Add 135 µL cell culture media into the ECM/Component mixture from step 2 to yield a final hydrogel concentration of 6 mg/mL. Mix thoroughly by vortexing. Note: While
1/9